These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29066124)

  • 1. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
    Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma knife radiosurgery in younger patients with vestibular schwannomas.
    Lobato-Polo J; Kondziolka D; Zorro O; Kano H; Flickinger JC; Lunsford LD
    Neurosurgery; 2009 Aug; 65(2):294-300; discussion 300-1. PubMed ID: 19625908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience.
    Aoyama H; Onodera S; Takeichi N; Onimaru R; Terasaka S; Sawamura Y; Shirato H
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):329-34. PubMed ID: 22704983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
    World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma.
    Chung HT; Ma R; Toyota B; Clark B; Robar J; McKenzie M
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1116-21. PubMed ID: 15234046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report.
    Poen JC; Golby AJ; Forster KM; Martin DP; Chinn DM; Hancock SL; Adler JR
    Neurosurgery; 1999 Dec; 45(6):1299-305; discussion 1305-7. PubMed ID: 10598696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption.
    Sawamura Y; Shirato H; Sakamoto T; Aoyama H; Suzuki K; Onimaru R; Isu T; Fukuda S; Miyasaka K
    J Neurosurg; 2003 Oct; 99(4):685-92. PubMed ID: 14567604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing.
    Han JH; Kim DG; Chung HT; Paek SH; Jung HW
    Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
    Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
    J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
    Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
    J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.
    Khattab MH; Sherry AD; Whitaker R; Wharton DM; Weaver KD; Chambless LB; Cmelak AJ; Attia A
    Neurosurgery; 2019 Dec; 85(6):E1078-E1083. PubMed ID: 31215628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing subclassification may predict long-term auditory outcomes after radiosurgery for vestibular schwannoma patients with good hearing.
    Mousavi SH; Niranjan A; Akpinar B; Huang M; Kano H; Tonetti D; Flickinger JC; Dade Lunsford L
    J Neurosurg; 2016 Oct; 125(4):845-852. PubMed ID: 26745482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution.
    Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Sawangsilpa T; Janwityanujit T; Yongvithisatid P
    J Radiat Res; 2014 Mar; 55(2):351-8. PubMed ID: 24142966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional study.
    Pikis S; Mantziaris G; Kormath Anand R; Nabeel AM; Sheehan D; Sheehan K; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad Eldin R; Peker S; Samanci Y; Kaisman-Elbaz T; Speckter H; Hernández W; Isidor J; Tripathi M; Madan R; Zacharia BE; Daggubati LC; Martínez Moreno N; Martínez Álvarez R; Langlois AM; Mathieu D; Deibert CP; Sudhakar VR; Cifarelli CP; Arteaga Icaza D; Cifarelli DT; Wei Z; Niranjan A; Barnett GH; Lunsford LD; Bowden GN; Sheehan JP
    J Neurosurg; 2023 Feb; 138(2):405-412. PubMed ID: 36303474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.
    Meijer OW; Vandertop WP; Baayen JC; Slotman BJ
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1390-6. PubMed ID: 12873685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.